Fundz

Who to call at Esperion Therapeutics, and when

Fundz watches for the moments Esperion Therapeutics starts buying, and tells you who to reach.

  • An alert the day Esperion Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Esperion Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Esperion Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Esperion Partners with Neopharm to Commercialize NEXLETOL® and NEXLIZET® in Israel

Dec 12, 2024

Contract Type

partnership

Ann ArborBiotechnologyHealth CareTherapeuticsPharmaceuticalpharmaceuticals

Description

Esperion Therapeutics has entered into a partnership with Neopharm Israel to grant exclusive rights for the commercialization of NEXLETOL® and NEXLIZET® in Israel. Neopharm, with over 80 years of experience in commercializing pharmaceutical products, aims to bring these innovative medicines to Israeli patients at risk of heart attacks and cardiovascular disease.

Company Information

Company

Esperion Therapeutics

Location

3891 Ranchero Dr

Ann Arbor, Michigan, United States

About

Esperion Therapeutics is a pharmaceutical company based in Ann Arbor, Michigan, focused on developing and commercializing innovative medicines for patients at risk for cardiovascular and cardiometabolic diseases.

Related People

Betty
Senior decision-maker at this company
••••••••@••••••••

See Betty's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Esperion Therapeutics's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Esperion Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.